Brief: Bluejay Diagnostics Announces Successful Completion Of Enrollment In The Symon-II Multicenter Clinical Validation Study
21/07/2026 11:55
BRIEF-Bluejay Diagnostics Announces Successful Completion Of Enrollment In The Symon-II Multicenter Clinical Validation Study July 21 (Reuters) - Bluejay Diagnostics Inc BJDX.O:
BLUEJAY DIAGNOSTICS ANNOUNCES SUCCESSFUL COMPLETION OF ENROLLMENT IN THE SYMON-II MULTICENTER CLINICAL VALIDATION STUDY
BLUEJAY DIAGNOSTICS - PRELIMINARY SYMON-II DATA SHOW 17% 28-DAY MORTALITY RATE
Source text: ID:nGNX4FK3g0
Further company coverage: BJDX.O
(Reporting by Shania S Thomas)
((ShaniaS.Thomas@thomsonreuters.com;))
Recent news on Bluejay Diagnostics
See all newsBrief: Bluejay Diagnostics Announces Successful Completion Of Enrollment In The Symon-II Multicenter Clinical Validation Study
Brief: Bluejay Diagnostics And Argonaut Manufacturing Services Announce Strategic Partnership
Bluejay Diagnostics Q1 net loss unchanged
Brief: Bluejay Diagnostics, Inc. Announces Completion Of 624 Patient Enrollments In Symon-Ii Pivotal Clinical Trial
Brief: Bluejay Diagnostics Provides Corporate Update And 2026 Strategic Outlook